Browsing by Author Bell, KJL

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
1-Jan-2014Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: Secondary analysis of observational study dataBell, KJL; Beller, E; Sundström, J; McGeechan, K; Hayen, A; Irwig, L; Neal, B; Glasziou, P
17-Jan-2017Change in bone mineral density is an indicator of treatment-related antifracture effectBell, KJL; Hayen, A; Glasziou, P; Irwig, L; Bauer, DC
1-Feb-2014Criteria for monitoring tests were described: Validity, responsiveness, detectability of long-term change, and practicalityBell, KJL; Glasziou, PP; Hayen, A; Irwig, L
29-Jan-2011Monitoring adherence to drug treatment by using change in cholesterol concentration: Secondary analysis of trial dataBell, KJL; Kirby, A; Hayen, A; Irwig, L; Glasziou, P
10-Dec-2011Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanomaTurner, RM; Bell, KJL; Morton, RL; Hayen, A; Francken, AB; Howard, K; Armstrong, B; Thompson, JF; Irwig, L
1-Jan-2012The potential value of monitoring bone turnover markers among women on alendronateBell, KJL; Hayen, A; Irwig, L; Hochberg, MC; Ensrud, KE; Cummings, SR; Bauer, DC
1-Apr-2018Prognostic impact of systolic blood pressure variability in people with diabetesBell, KJL; Azizi, L; Nilsson, PM; Hayen, A; Irwig, L; Östgren, CJ; Sundröm, J
4-May-2013When to remeasure cardiovascular risk in untreated people at low and intermediate risk: Observational studyBell, KJL; Hayen, A; Irwig, L; Takahashi, O; Ohde, S; Glasziou, P